| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |